RECURRENT WALDENSTROM MACROGLOBULINEMIA
Clinical trials for RECURRENT WALDENSTROM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WALDENSTROM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for RECURRENT WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Oral drug combo tested for rare blood cancer
Disease control TerminatedThis study tested a combination of two oral drugs, ibrutinib and ixazomib, for people with Waldenström macroglobulinemia, a rare type of blood cancer. The goal was to see if taking these two drugs together was safe and effective at controlling the cancer. The trial was designed f…
Matched conditions: RECURRENT WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 04, 2026 03:19 UTC
-
New drug tested for Tough-to-Treat blood cancer
Disease control TerminatedThis early-phase study aimed to find the safest and most effective dose of the drug pomalidomide for patients with Waldenstrom macroglobulinemia, a rare blood cancer that had returned or stopped responding to prior treatments. The trial enrolled 15 patients to carefully monitor s…
Matched conditions: RECURRENT WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC